Cystatin C as a biomarker for estimating glomerular filtration rate

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 3, 2015, Pages 295-300

  Ferguson, Thomas W ^a   Komenda, Paul ^a   Tangri, Navdeep ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

chronic kidney disease; creatinine; cystatin C; glomerular filtration rate; risk prediction

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIET; GLOMERULUS FILTRATION RATE; MORTALITY; MUSCLE MASS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; BLOOD; HUMAN; KIDNEY FUNCTION TEST; PHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

BIOMARKERS; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84928492951     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000115     Document Type: Review

References (32)

1. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483.
2. GoAS, ChertowGM,Fan D, et al.Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
3. Walker SR, Gill K, Macdonald K, et al. Association of frailty and physical function in patients with nondialysis CKD: a systematic review. BMC Nephrol 2013; 14:228. doi: 10.1186/1471-2369-14-228.
4. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20:2305-2313.
5. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
6. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
7. Tangri N, Stevens LA, Schmid CH, et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int 2011; 79:471-477.
8. Shlipak MG, Matsushita K, Arnlov J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369:932-943.
9. Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens 2011; 20:631-639.
10. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36:29-34.
11. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem 2012; 58:680-689.
12. Filler G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38:1-8.
13. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47:312-318.
14. Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43:1016-1022.
15. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226.
16. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2006; 15:610-616.
17. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004; 41:467-550.
18. Chew JS, Saleem M, Florkowski CM, George PM. Cystatin C-a paradigm of evidence based laboratory medicine. Clin Biochem Rev 2008; 29: 47-62.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
20. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3:348-354.
21. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305:1545-1552.
22. Tangri N, Inker LA, Tighiouart H, et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 2012; 23:351-359.
23. Herget-Rosenthal S, Bokenkamp A, Hofmann W. How to estimate GFRserum creatinine, serum cystatin C or equations? Clin Biochem 2007; 40:153-161.
24. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44:1535-1539.
25. Schwartz GJ, Schneider MF, Maier PS, et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 2012; 82:445-453.
26. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20-29.
27. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
28. Rule AD, Bailey KR, Lieske JC, et al. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013; 83:1169-1176.
29. Shlipak MG, Weekley CC, Li Y, et al. Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the Heart and Soul Study. Clin Chem 2011; 57:737-745.
30. Pencina MJ, D'Agostino RBS, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion 207-212.
31. Leening MJ, Vedder MM, Witteman JC, et al. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med 2014; 160:122-131.
32. Tsai CW, Grams ME, Inker LA, et al. Cystatin C-and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. Diabetes Care 2014; 37:1002-1008.